Health Catalyst (NASDAQ:HCAT – Get Free Report) and Viant Technology (NASDAQ:DSP – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, earnings and institutional ownership.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Health Catalyst and Viant Technology, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Health Catalyst | 0 | 3 | 7 | 0 | 2.70 |
| Viant Technology | 0 | 0 | 8 | 0 | 3.00 |
Health Catalyst presently has a consensus target price of $8.05, suggesting a potential upside of 92.02%. Viant Technology has a consensus target price of $21.00, suggesting a potential upside of 44.43%. Given Health Catalyst’s higher possible upside, analysts plainly believe Health Catalyst is more favorable than Viant Technology.
Risk & Volatility
Earnings and Valuation
This table compares Health Catalyst and Viant Technology”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Health Catalyst | $306.58 million | 0.96 | -$118.15 million | ($1.15) | -3.64 |
| Viant Technology | $289.24 million | 3.17 | -$3.44 million | $0.12 | 121.17 |
Viant Technology has lower revenue, but higher earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than Viant Technology, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Health Catalyst and Viant Technology’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Health Catalyst | -26.20% | -7.51% | -3.72% |
| Viant Technology | 0.47% | -5.67% | -3.78% |
Insider and Institutional Ownership
85.0% of Health Catalyst shares are owned by institutional investors. Comparatively, 11.4% of Viant Technology shares are owned by institutional investors. 2.5% of Health Catalyst shares are owned by company insiders. Comparatively, 28.8% of Viant Technology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Summary
Viant Technology beats Health Catalyst on 9 of the 14 factors compared between the two stocks.
About Health Catalyst
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
About Viant Technology
Viant Technology Inc. operates as an advertising technology company. It provides Household ID, a people-based innovation that combines digital and personal identifiers into a normalized household profile; AI Bid Optimizer, solution that uses AI to analyze historical bid opportunities to predict the lowest media cost for desired advertisement; and Viant Data Platform, which offers marketers control over their own data with actionable insights into their marketing initiatives within a single platform. The company also offers Holistic, an omnichannel DSP for marketers and their agencies to manage omnichannel campaigns and access metrics from each channel to inform decisions in other channels; Viant Identity Graph, which reduces or eliminates the need for cookies by enabling matching of people-based identifiers that anchor digital identifiers that allows marketers to reach targeted consumers in a privacy-conscious manner; and Direct Access, a path optimization program. In addition, it provides campaign analysis and data intelligence tool that empowers customers with differentiated insights, including conversion lift, multi-touch attribution, foot-traffic data reports, digital-out-of-home lift, sales reporting, and ROAS analytics; and self-service platform that provides customers with transparency and control over their advertising campaigns and underlying data infrastructure. The company sells its platform through a direct sales team focused on business development in various markets. It serves purchasers of programmatic advertising inventory; and large, independent, and mid-market advertising agencies, as well as marketers. The company was founded in 1999 and is headquartered in Irvine, California.
Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.
